Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status

被引：13
|
作者：
Bhayani, SB [1 ]
Allaf, ME [1 ]
Kavoussi, LR [1 ]
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21287 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2004年 / 22卷 / 02期
关键词：
testis cancer; lymphadenectomy; retroperitoneal lymph node dissection; germ cell tumor;
D O I：
10.1016/j.urolonc.2004.01.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码：145 / 148
页数：4
相关论文
共 50 条
  • [41] A rational approach to managing stage I nonseminomatous germ cell cancer
    Lashley, DB
    Lowe, BA
    UROLOGIC CLINICS OF NORTH AMERICA, 1998, 25 (03) : 405 - +
  • [42] Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program Editorial Comment
    Richie, Jerome P.
    JOURNAL OF UROLOGY, 2010, 183 (02): : 558 - 559
  • [43] Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: Long term evaluation of cancer control
    Bhayani, SB
    Ong, A
    Chan, D
    Pinto, P
    Oh, WK
    Kantoff, PW
    Kavoussi, LR
    JOURNAL OF UROLOGY, 2003, 169 (04): : 241 - 241
  • [44] The value of prognostic factors in the management of Stage I nonseminomatous germ cell testicular tumors (NSGCTT)
    Ondrus, D
    Goncalves, F
    Kausitz, J
    Matoska, J
    Belan, V
    NEOPLASMA, 1996, 43 (03) : 195 - 197
  • [45] EXTRAPERITONEAL LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR EARLY STAGE TESTICULAR NONSEMINOMATOUS GERM CELL TUMORS
    Yin, Changjun
    JOURNAL OF ENDOUROLOGY, 2011, 25 : A163 - A164
  • [46] Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance
    Hao, D
    Seidel, J
    Brant, R
    Alexander, F
    Ernst, DS
    Summers, N
    Russell, JA
    Stewart, DA
    JOURNAL OF UROLOGY, 1998, 160 (03): : 768 - 771
  • [47] Open versus laparoscopic retroperitoneal lymph node dissection (RPLND) in clinical stage I nonseminomatous germ-cell tumors (NSGCTs): Two contemporary series from a single institution
    Nicolai, N.
    Biasoni, D.
    Aguilera, J. Piedra
    Necchi, A.
    Piva, L.
    Stagni, S.
    Torelli, T.
    Milani, A.
    Pizzocaro, G.
    Salvioni, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance
    Hamilton, Robert J.
    Nayan, Madhur
    Anson-Cartwright, Lynn
    Atenafu, Eshetu G.
    Bedard, Philippe L.
    Hansen, Aaron
    Chung, Peter
    Warde, Padraig
    Sweet, Joan
    O'Malley, Martin
    Sturgeon, Jeremy
    Jewett, Michael A. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (22) : 1919 - +
  • [49] Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours
    Pedraza, Adriana M.
    Stephenson, Andrew J.
    CURRENT OPINION IN UROLOGY, 2018, 28 (05) : 448 - 453
  • [50] Histopathologic Predictors of Relapse in Clinical Stage I Nonseminomatous Germ Cell Tumors
    Yilmaz, A.
    Trpkov, K.
    Cheng, T.
    MODERN PATHOLOGY, 2010, 23 : 230A - 230A
12345